Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
| Autor: | Zhu, Feng-Cai ***, Li, Yu-Hua, Guan, Xu-Hua, Hou, Li-Hua, Wang, Wen-Juan, Li, Jing-Xin, Wu, Shi-Po, Wang, Bu-Sen, Wang, Zhao, Wang, Lei, Jia, Si-Yue, Jiang, Hu-Dachuan, Wang, Ling, Jiang, Tao, Hu, Yi, Gou, Jin-Bo, Xu, Sha-Bei, Xu, Jun-Jie, Wang, Xue-Wen, Wang, Wei **, Chen, Wei * |
|---|---|
| Zdroj: | In The Lancet 13-19 June 2020 395(10240):1845-1854 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|